Intracellular selection of trans-cleaving hammerhead ribozymes

被引:22
作者
Huang, Xin [1 ]
Zhao, Yongyun [2 ]
Pu, Qinlin [1 ]
Liu, Getong [1 ]
Peng, Yan [1 ]
Wang, Fei [1 ]
Chen, Gangyi [1 ]
Sun, Meiling [1 ]
Du, Feng [1 ]
Dong, Juan [1 ]
Cui, Xin [1 ]
Tang, Zhuo [1 ]
Mo, Xianming [2 ]
机构
[1] Chinese Acad Sci, Nat Prod Res Ctr, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Lab Stem Cell Biol, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
基金
中国科学院西部之光基金;
关键词
CLEAVAGE; DISCOVERY; HIV; RNA; VARIANTS; CELLS; TRIAL;
D O I
10.1093/nar/gkz018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hammerhead ribozyme is the smallest and best characterized catalytic RNA-cleaving ribozyme. It has been reported as potential therapeutic tools to manipulate the expression of target genes. However, most of naturally occurring hammerhead ribozymes process self-cleavage rather than cleave substrate RNA in trans, and its high intracellular activity relies on the tertiary interaction of Loop II and steam I bulge, resulting in decreased performance as applied in gene silencing. We described a direct intracellular selection method to evolve hammerhead variants based on trans-cleavage mode via using a toxin gene as the reporter. And a dual fluorescence proteins system has also been established to quantitatively evaluate the efficiency of selected ribozymes in the cell. Based on this selection strategy, we obtained three mutants with enhanced intracellular cleaving activity compared to wide type hammerhead ribozyme. The best one, TX-2 was revealed to possess better and consistent gene knockdown ability at different positions on diverse targeted mRNA either in prokaryotic or eukaryotic cells than wild-type hammerhead ribozyme. These observations imply the efficiency of the intracellular selection method of the trans-acting ribozyme and the potentials of improved ribozyme variants for research and therapeutic purposes.
引用
收藏
页码:2514 / 2522
页数:9
相关论文
共 38 条
[1]   Gene discovery by ribozyme and siRNA libraries [J].
Akashi, H ;
Matsumoto, S ;
Taira, K .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (05) :413-422
[2]   A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme [J].
Amado, RG ;
Mitsuyasu, RT ;
Symonds, G ;
Rosenblatt, JD ;
Zack, J ;
Sun, LO ;
Miller, M ;
Ely, J ;
Gerlach, W .
HUMAN GENE THERAPY, 1999, 10 (13) :2255-+
[3]   Autologous cell therapy for HIV Stem cells, ribozymes and HIV [J].
Burnett, J. C. ;
Rossi, J. J. .
GENE THERAPY, 2009, 16 (10) :1178-1179
[4]   AN OLIGODEOXYRIBONUCLEOTIDE THAT SUPPORTS CATALYTIC ACTIVITY IN THE HAMMERHEAD RIBOZYME DOMAIN [J].
CHARTRAND, P ;
HARVEY, SC ;
FERBEYRE, G ;
USMAN, N ;
CEDERGREN, R .
NUCLEIC ACIDS RESEARCH, 1995, 23 (20) :4092-4096
[5]   Direct selection for ribozyme cleavage activity in cells [J].
Chen, Xi ;
Denison, Lisa ;
Levy, Matthew ;
Ellington, Andrew D. .
RNA, 2009, 15 (11) :2035-2045
[6]   Selected classes of minimised hammerhead ribozyme have very high cleavage rates at low Mg2+ concentration [J].
Conaty, J ;
Hendry, P ;
Lockett, T .
NUCLEIC ACIDS RESEARCH, 1999, 27 (11) :2400-2407
[7]   Peripheral regions of natural hammerhead ribozymes greatly increase their self-cleavage activity [J].
De la Peña, M ;
Gago, S ;
Flores, R .
EMBO JOURNAL, 2003, 22 (20) :5561-5570
[8]   The chemical repertoire of natural ribozymes [J].
Doudna, JA ;
Cech, TR .
NATURE, 2002, 418 (6894) :222-228
[9]   KINETICS OF INTERMOLECULAR CLEAVAGE BY HAMMERHEAD RIBOZYMES [J].
FEDOR, MJ ;
UHLENBECK, OC .
BIOCHEMISTRY, 1992, 31 (48) :12042-12054
[10]   Abundance of type I toxin-antitoxin systems in bacteria: searches for new candidates and discovery of novel families [J].
Fozo, Elizabeth M. ;
Makarova, Kira S. ;
Shabalina, Svetlana A. ;
Yutin, Natalya ;
Koonin, Eugene V. ;
Storz, Gisela .
NUCLEIC ACIDS RESEARCH, 2010, 38 (11) :3743-3759